Share this post on:

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 12/2021”.

The Monitor is a monthly published overview of venture capital trends in the European Life Sciences sector.

As of the end of December 2021 we identify the following current VC trends in Europe:

  • In 2021, overall Life Sciences funding has reached EUR 13,874m
  • Top 5 Deals exceed EUR 200m each, largest transaction amounted to EUR 497m in CMR Surgical Ltd. (United Kingdom)
  • Novo Holdings (Denmark) dominates the Top 5 Investors (by deal volume), followed by BlackRock (USA) and Fidelity Management & Research (USA)
  • The MedTech sector received 32% of the total investment volume (-5% points compared to the previous month)
  • Central Nervous System dominates as the top indication of the Biotechnology sector

To access the full report, please click here.

By Dr. Mathias Schott and Sebastian Sommer

Source link

Share this post on:

Leave a Comment

Your email address will not be published. Required fields are marked *